Literature DB >> 16931038

Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production.

Susan L Kalled1.   

Abstract

The development of the B cell lineage has been extensively studied along with the soluble and cellular components involved in the maturation and selection process. It was not always clear, however, what factors were involved in supporting mature B cell survival. Identification of the B cell survival factor, BAFF, was a key discovery in understanding the survival mechanism for mature B cells in the periphery. More recent investigations have illuminated roles for BAFF in B cell biology outside of a survival mechanism. These include germinal center maintenance, isotype switching, and regulation of specific B cell surface markers. More importantly, a role for BAFF in B cell biology has been validated in vivo in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931038     DOI: 10.1016/j.smim.2006.06.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  45 in total

1.  Cellular competition independent of BAFF/B lymphocyte stimulator results in low frequency of an autoreactive clonotype in mature polyclonal B cell compartments.

Authors:  Neda Nikbakht; Thi-Sau Migone; Chris P Ward; Tim Manser
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

2.  TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.

Authors:  Zhangguo Chen; Alexandra Krinsky; Rachel A Woolaver; Xiaoguang Wang; Samantha M Y Chen; Vince Popolizio; Ping Xie; Jing H Wang
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

Review 3.  B cells as therapeutic targets in SLE.

Authors:  Iñaki Sanz; F Eun-Hyung Lee
Journal:  Nat Rev Rheumatol       Date:  2010-06       Impact factor: 20.543

Review 4.  Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.

Authors:  Victor H Engelhard; Anthony B Rodriguez; Ileana S Mauldin; Amber N Woods; J David Peske; Craig L Slingluff
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 5.  The rationale for BAFF inhibition in systemic lupus erythematosus.

Authors:  Anne Davidson
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

Review 6.  Targeting BAFF in autoimmunity.

Authors:  Anne Davidson
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

7.  NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency.

Authors:  Laurie T Krug; Christopher M Collins; Lisa M Gargano; Samuel H Speck
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

Review 8.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

9.  Expanding mechanistic insights into the pathogenesis of idiopathic CD4+ T cell lymphocytopenia.

Authors:  Jose S Campos; Sarah E Henrickson; Roshini S Abraham
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

10.  IFN-β treatment requires B cells for efficacy in neuroautoimmunity.

Authors:  Ryan D Schubert; Yang Hu; Gaurav Kumar; Spencer Szeto; Peter Abraham; Johannes Winderl; Joel M Guthridge; Gabriel Pardo; Jeffrey Dunn; Lawrence Steinman; Robert C Axtell
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.